Form 4: Anixa Biosciences Director Boosts Stake with Significant Stock Purchase

Anixa Biosciences Inc. Director Lewis H. Titterton Jr. purchased 10,000 shares of common stock at $3.14 per share, increasing his direct beneficial ownership to 943,334 shares.

Summary

• Lewis H. Titterton Jr., a Director of Anixa Biosciences Inc. (ANIX), acquired 10,000 shares of common stock.
• The transaction occurred on July 11, 2025, at a price of $3.14 per share.
• Following this purchase, Mr. Titterton's direct beneficial ownership in Anixa Biosciences Inc. stands at 943,334 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: The purchase of shares by a director generally indicates confidence in the company's future, which is a positive signal for investors.

Positives

• A director's purchase of company stock can signal confidence in the company's future prospects and valuation.
• The acquisition of 10,000 shares by Director Lewis H. Titterton Jr. increases his direct beneficial ownership to 943,334 shares, further aligning his interests with shareholders.

Negatives

• No explicit negatives are detailed in this Form 4 filing, which primarily reports an insider transaction.

Risks

• No specific risks are detailed in this Form 4 filing, as it is a transaction report, not a comprehensive risk disclosure.

Future Outlook

This document is a transaction report and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• This regulatory filing reports a transaction and does not contain direct management quotes or paraphrased statements beyond the transaction details.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Comparison to Industry Standards

• This document is a specific insider transaction report and does not provide data for comparison to industry benchmarks or specific comparable companies/projects.

Corporate Governance

Related Party Transactions

• Purchase of 10,000 shares of common stock by Lewis H. Titterton Jr., a Director of Anixa Biosciences Inc., at $3.14 per share.

Stakeholder Impact

• Shareholders: A director's purchase can be seen as a positive signal, potentially increasing investor confidence in the company's prospects.

Next Steps

• No specific future actions, events, or milestones are mentioned in this transaction report.

Key Dates

Keywords

Anixa Biosciences, ANIX, Insider Trading, Form 4, Stock Purchase, Director, Beneficial Ownership, Equity, SEC Filing, Lewis H. Titterton Jr.